by Ashley | Aug 7, 2020 | Blog, Personalized Stem Cells, Stem Cell Therapy
As co-founders of leading regenerative veterinary medicine company, VetStem Biopharma, Dr. Bob Harman and Michael Dale, saw a real need to advance and legitimize stem cell therapy in the human medical field. As we’ve briefly discussed in previous blogs, stem cells...
by Ashley | Jul 10, 2020 | Blog, Knee Osteoarthritis, Stem Cell Therapy, Stem Cells for Knees
It is estimated that more than 600,000 knee replacement surgeries are performed each year in the United States. Doctors recommend knee replacement for patients with severe joint damage, pain, limited mobility, and those who do not respond well to traditional treatment...
by Ashley | May 22, 2020 | Blog, FDA Approved Clinical Trial, Stem Cell Therapy
Stem cells can differentiate into multiple tissue types such as bone, cartilage, muscle, and even cardiac and nerve tissues. They are sometimes called the “master cells” of the body. Literature demonstrates that stem cells have the ability to repair, regenerate, and...
by Ashley | Apr 24, 2020 | Blog, COVID-19, Stem Cell Therapy
Personalized Stem Cells, Inc. (PSC) has filed a request for expedited review of an FDA Investigational New Drug (IND) for the treatment of COVID-19 patients with stem cells. The White House Coronavirus Task Force asked PSC to apply through the new FDA Coronavirus...
by Ashley | Apr 21, 2020 | COVID-19, FDA Approved Clinical Trial, Personalized Stem Cells, Press Release, Stem Cell Therapy
Personalized Stem Cells, Inc. (PSC) and its parent company, VetStem Biopharma, have filed an expedited review request for an Investigational New Drug (IND) application with the FDA for the treatment of COVID-19 patients with stem cells. The first trial is named...
by Valet | Apr 14, 2020 | Blog, COVID-19, Stem Cell Therapy
Recently, Personalized Stem Cells (PSC) was asked by the White House Task Force to apply to the FDA for expedited review of their application for using stem cells to treat patients with COVID-19. Stem cell therapy is a distinct approach that treats lung inflammation...